Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Mitochondrial pyruvate import is a metabolic vulnerability in androgen receptor-driven prostate cancer
David Bader, Sean M. Hartig, Vasanta Putluri, et al.
Nature Metabolism (2018) Vol. 1, Iss. 1, pp. 70-85
Open Access | Times Cited: 147

Showing 26-50 of 147 citing articles:

Androgen Receptor Signaling and Metabolic and Cellular Plasticity During Progression to Castration Resistant Prostate Cancer
Takuma Uo, Cynthia C.T. Sprenger, Stephen R. Plymate
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 57
The Spatial and Genomic Hierarchy of Tumor Ecosystems Revealed by Single-Cell Technologies
Eric A. Smith, H. Courtney Hodges
Trends in cancer (2019) Vol. 5, Iss. 7, pp. 411-425
Open Access | Times Cited: 56
Fatty Acid Synthesis in Prostate Cancer: Vulnerability or Epiphenomenon?
Laura A. Sena, Samuel R. Denmeade
Cancer Research (2021) Vol. 81, Iss. 17, pp. 4385-4393
Open Access | Times Cited: 56
The Importance of Mitochondrial Pyruvate Carrier in Cancer Cell Metabolism and Tumorigenesis
Ainhoa Ruiz-Iglesias, Santos Mañes
Cancers (2021) Vol. 13, Iss. 7, pp. 1488-1488
Open Access | Times Cited: 53
Role of Mitochondrial Stress Response in Cancer Progression
Yu Geon Lee, Do Hong Park, Young Chan Chae
Cells (2022) Vol. 11, Iss. 5, pp. 771-771
Open Access | Times Cited: 38
The mitochondrial pyruvate carrier at the crossroads of intermediary metabolism
Nicole K.H. Yiew, Brian N. Finck
AJP Endocrinology and Metabolism (2022) Vol. 323, Iss. 1, pp. E33-E52
Open Access | Times Cited: 38
Metabolic changes during prostate cancer development and progression
Alicia-Marie K. Beier, Martin Puhr, Matthias B. Stope, et al.
Journal of Cancer Research and Clinical Oncology (2022) Vol. 149, Iss. 5, pp. 2259-2270
Open Access | Times Cited: 38
Lipid Metabolism and Epigenetics Crosstalk in Prostate Cancer
Juan Carlos Triviño Pardo, Vicenç Ruiz de Porras, Joan Gil, et al.
Nutrients (2022) Vol. 14, Iss. 4, pp. 851-851
Open Access | Times Cited: 34
Prostate lineage-specific metabolism governs luminal differentiation and response to antiandrogen treatment
Jenna M. Giafaglione, Preston D. Crowell, Amelie M.L. Delcourt, et al.
Nature Cell Biology (2023) Vol. 25, Iss. 12, pp. 1821-1832
Open Access | Times Cited: 22
Fifty years of the mitochondrial pyruvate carrier: New insights into its structure, function, and inhibition
Sotiria Tavoulari, Maximilian Sichrovsky, Edmund R.S. Kunji
Acta Physiologica (2023) Vol. 238, Iss. 4
Open Access | Times Cited: 21
Metabolomic profiling for the identification of novel diagnostic markers and therapeutic targets in prostate cancer: an update
Giuseppe Lucarelli, Davide Loizzo, Matteo Ferro, et al.
Expert Review of Molecular Diagnostics (2019) Vol. 19, Iss. 5, pp. 377-387
Closed Access | Times Cited: 53
Cancer cell metabolism: Rewiring the mitochondrial hub
Gabriela Lopes Oliveira, Ana R. Coelho, Ricardo Marques, et al.
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease (2020) Vol. 1867, Iss. 2, pp. 166016-166016
Open Access | Times Cited: 50
COX6B2 drives metabolic reprogramming toward oxidative phosphorylation to promote metastasis in pancreatic ductal cancer cells
Ke Nie, Jin Li, Xujun He, et al.
Oncogenesis (2020) Vol. 9, Iss. 5
Open Access | Times Cited: 48
Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting
Beatrice Parma, Vignesh Ramesh, Paradesi Naidu Gollavilli, et al.
Journal of Experimental & Clinical Cancer Research (2021) Vol. 40, Iss. 1
Open Access | Times Cited: 35
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
Chia‐Lin Chen, Ching‐Yu Lin, Hsing‐Jien Kung
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13435-13435
Open Access | Times Cited: 33
Key features of inhibitor binding to the human mitochondrial pyruvate carrier hetero-dimer
Sotiria Tavoulari, Tom J.J. Schirris, Vasiliki Mavridou, et al.
Molecular Metabolism (2022) Vol. 60, pp. 101469-101469
Open Access | Times Cited: 24
Membrane transporters in cell physiology, cancer metabolism and drug response
Sara Alam, Emily Doherty, Paula Ortega-Prieto, et al.
Disease Models & Mechanisms (2023) Vol. 16, Iss. 11
Open Access | Times Cited: 16
Mechanisms of Prostate Cancer Cells Survival and Their Therapeutic Targeting
T. Pejcic, Zoran Todorović, Siniša Đurašević, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 3, pp. 2939-2939
Open Access | Times Cited: 15
Therapeutic implications of cancer stem cells in prostate cancer
Pinaki P. Banerjee, Prachi Kapse, Shehnaz Siddique, et al.
Cancer Biology and Medicine (2023), pp. 1-20
Open Access | Times Cited: 14
Mitochondrial reprogramming by activating OXPHOS via glutamine metabolism in African American patients with bladder cancer
Karthik Reddy Kami Reddy, Danthasinghe Waduge Badrajee Piyarathna, Jun Hyoung Park, et al.
JCI Insight (2024) Vol. 9, Iss. 17
Open Access | Times Cited: 6
Enzalutamide, an Androgen Receptor Antagonist, Enhances Myeloid Cell–Mediated Immune Suppression and Tumor Progression
Camila Rosat Consiglio, Olga Udartseva, Kimberly D. Ramsey, et al.
Cancer Immunology Research (2020) Vol. 8, Iss. 9, pp. 1215-1227
Open Access | Times Cited: 36
20,000 picometers under the OMM: diving into the vastness of mitochondrial metabolite transport
Corey N. Cunningham, Jared Rutter
EMBO Reports (2020) Vol. 21, Iss. 5
Open Access | Times Cited: 34
Recent Advances in Electrochemical Biosensors for Monitoring Animal Cell Function and Viability
Kyeong‐Mo Koo, Chang‐Dae Kim, Fu Nan Ju, et al.
Biosensors (2022) Vol. 12, Iss. 12, pp. 1162-1162
Open Access | Times Cited: 21
Mitochondrial pyruvate supports lymphoma proliferation by fueling a glutamate pyruvate transaminase 2–dependent glutaminolysis pathway
Wei Peng, Alex J. Bott, Ahmad A. Cluntun, et al.
Science Advances (2022) Vol. 8, Iss. 39
Open Access | Times Cited: 20
Pyruvate anaplerosis is a targetable vulnerability in persistent leukaemic stem cells
Kevin M. Rattigan, Zuzana Brabcova, Daniele Sarnello, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 13

Scroll to top